Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Pfizer: Ganz stark!
Pfizer: Ganz stark!
Lieber Leser, die gescheiterte Übernahme von Allergan schien der Pfizer-Aktie einen empfindlichen Dämpfer verpasst zu haben – von wegen! Nachdem der Pharmakonzern jüngst glänzende Zahlen fürs erste Quartal
Der Biotech-Sektor im Aufwind und was das mit dem geplatzten Pfizer/Allergan-Deal zu tun hat
Der Biotech-Sektor im Aufwind und was das mit dem geplatzten Pfizer/Allergan-Deal zu tun hat
Liebe Leser, nun ist es amtlich. Obama hat den Pfizer/Allergan-Deal platzen lassen wie eine Blase. Der seit November 2015 geplante, größte Deal der Geschichte wurde gestern im Laufe des Tages von Pfizer abgesagt.
Pfizer/ Allergan: Was geht denn da ab?
Pfizer/ Allergan: Was geht denn da ab?
Liebe Leser, die Nachrichten um den möglicherweise geplatzten Deal zwischen dem Botox-Hersteller Allergan und dem einem der größten Arzneimittelhersteller Pfizer scheinen sich zu verdichten, leider weniger
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.: https://g.foolcdn.com/editorial/images/775349/time-to-buy.jpg
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.

Pfizer (NYSE: PFE) stock is an investing enigma. The drugmaker's shares have printed fresh 52-week lows consistently over the past two years, putting its stock in serious bargain territory. Speaking

Pfizer (PFE) Q1 2024 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
Pfizer (PFE) Q1 2024 Earnings Call Transcript

Image source: The Motley Fool.

Pfizer (NYSE: PFE)Q1 2024 Earnings CallMay 01, 2024, 10:00 a.m. ET

Operator

Continue reading

Source Fool.com

Why Pfizer Stock Blasted More Than 6% Higher Today: https://g.foolcdn.com/editorial/images/775390/medical-professional-holding-dollar-sign-paperweight.jpg
Why Pfizer Stock Blasted More Than 6% Higher Today

Pfizer (NYSE: PFE) stock got a very effective shot in the arm on Wednesday. This was supplied by its latest earnings release, which saw the storied pharmaceutical company notch double beats on

5 Top Stocks to Buy in May: https://g.foolcdn.com/editorial/images/774654/gettyimages-1032524356-1201x691-f260cd6-1.jpg
5 Top Stocks to Buy in May

Earnings season is officially here. As per usual, there have already been epic sell-offs and run-ups across well-known names.

However, long-term investors know that the best way to view a quarterly

Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist: https://g.foolcdn.com/editorial/images/774882/scientists-looking-at-screen-with-icons.jpg
Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist

I owned shares of Pfizer (NYSE: PFE) when the COVID-19 pandemic started. Watching the stock soar over 60% in roughly two years was fun. Seeing Pfizer's share price fall nearly 60% from its peak

3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street: https://g.foolcdn.com/editorial/images/774353/solar-panels-with-engineers.jpg
3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street

Income investors can be growth investors, too. Granted, it's not always easy to find stocks that pay generous dividends and offer solid prospects of share price appreciation. However, such stocks

Forget Nvidia, These Unstoppable Stocks Are Better Buys: https://g.foolcdn.com/editorial/images/773650/a-couple-meeting-with-an-advisor.jpg
Forget Nvidia, These Unstoppable Stocks Are Better Buys

Nvidia has been an amazing stock to own over the past few years, generating incredible returns for investors. But the risk is that expectations may be too high for the stock, especially with respect

This Healthcare Stock Just Gave Investors 100 Billion Reasons to Buy It: https://g.foolcdn.com/editorial/images/773165/person-giving-the-thumbs-up-after-receiving-a-vaccination-shot.jpg
This Healthcare Stock Just Gave Investors 100 Billion Reasons to Buy It

It's still early days in this latest earnings season, but it seems we can already tag one winner in the healthcare sector -- take a bow, UnitedHealth Group (NYSE: UNH).

As the season lurched into

Want $2,000 in Annual Dividends? Invest $30,000 in These 3 Stocks: https://g.foolcdn.com/editorial/images/773640/a-couple-looking-at-a-tablet-during-breakfast.jpg
Want $2,000 in Annual Dividends? Invest $30,000 in These 3 Stocks

"If you don't find a way to make money while you sleep, you will work until you die." That's a quote from billionaire investor Warren Buffett which emphasizes the importance of making your money

If You'd Invested $1,000 in Pfizer 5 Years Ago, Here's How Much You'd Have Today: https://g.foolcdn.com/editorial/images/773023/getty-doubtful-expression-skeptical-not-sure-disbelieving-surprised.jpg
If You'd Invested $1,000 in Pfizer 5 Years Ago, Here's How Much You'd Have Today

If you had bought $1,000 worth of Pfizer (NYSE: PFE) shares five years ago, how much would that be worth today? The answer will strike you as terrific or terrible: $840.

That answer will be terrible

UnitedHealth Group (UNH) Q1 2024 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
UnitedHealth Group (UNH) Q1 2024 Earnings Call Transcript

Image source: The Motley Fool.

UnitedHealth Group (NYSE: UNH)Q1 2024 Earnings CallApr 16, 2024, 8:45 a.m. ET

Operator

Continue reading

Source Fool.com

Why UnitedHealth Group Stock Is Jumping Today: https://g.foolcdn.com/editorial/images/773085/healthcare-worker-ipad-nurse-doctor-hospital.jpg
Why UnitedHealth Group Stock Is Jumping Today

Shares of UnitedHealth Group (NYSE: UNH) were jumping 5.7% higher as of 11:17 a.m. ET on Tuesday after rising as much as 7.7% earlier in the day. The solid gain came after the giant healthcare

Is Pfizer Stock a Buy?: https://g.foolcdn.com/editorial/images/771826/two-investors-look-concerned-as-another-speaks.jpg
Is Pfizer Stock a Buy?

Pfizer (NYSE: PFE) isn't exactly a hot stock right now. Since its massive run-up during the pandemic's height, built on hopes for its coronavirus vaccine, new sources of growth haven't led to

2 Unstoppable Stocks to Buy and Hold Forever: https://g.foolcdn.com/editorial/images/772578/doctor-and-patient-in-a-hospital-room.jpg
2 Unstoppable Stocks to Buy and Hold Forever

Investing for the long term, as opposed to day trading, offers many benefits. Holding shares of companies for a while arguably brings more peace of mind, some tax advantages, and the ability for

2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever: https://g.foolcdn.com/editorial/images/772465/investment-advisor-getty.jpg
2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever

Income-seeking investors have to make an important choice when shopping for stocks to buy. Shares of companies that are likely to raise their dividend payouts at a rapid pace tend to offer low

Is Pfizer Stock the Biggest Bargain in the S&P 500?: https://g.foolcdn.com/editorial/images/772294/surprise-smartphone-news-stock-shock.jpg
Is Pfizer Stock the Biggest Bargain in the S&P 500?

Pfizer (NYSE: PFE) stock is relatively cheap. I can easily back up that claim. The big drugmaker's shares trade at lower forward earnings multiples than the S&P 500 and the S&P 500 healthcare

Where Will Pfizer Stock Be in 10 Years?: https://g.foolcdn.com/editorial/images/772094/businessperson-giving-a-presentation.jpg
Where Will Pfizer Stock Be in 10 Years?

Pfizer (NYSE: PFE) stock has been struggling for a while now. In the past 12 months, it has declined by 36%. A lack of growth recently, a dependence on acquisitions, and many question marks have

2 Ultra-High-Yield Dividend Stocks to Buy and Hold Forever: https://g.foolcdn.com/editorial/images/772254/dividends.jpg
2 Ultra-High-Yield Dividend Stocks to Buy and Hold Forever

Later this year, the Federal Reserve is projected to begin reducing interest rates. While the exact number of rate cuts is still uncertain, this regulatory action is expected to stimulate a surge in

Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead.: https://g.foolcdn.com/editorial/images/771899/gettyimages-1429005115.jpg
Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead.

One of the hottest themes in the pharmaceutical industry right now is weight loss. Medications specifically approved for weight loss, such as Wegovy and Zepbound, are taking the industry by storm.

Billionaire Ken Griffin Loaded Up on This High-Yield Dividend Stock. Should You?: https://g.foolcdn.com/editorial/images/772136/scientists-in-a-lab-smiling.jpg
Billionaire Ken Griffin Loaded Up on This High-Yield Dividend Stock. Should You?

If there were a hedge fund manager hall of fame, Ken Griffin would be a no-brainer inductee. His skillful leadership of Citadel made it one of the most successful hedge funds ever. It also made

This S&P 500 Dividend Stock Could Be the Best Bad-News Buy on the Market: https://g.foolcdn.com/editorial/images/771902/surprised-young-woman-laptop.jpg
This S&P 500 Dividend Stock Could Be the Best Bad-News Buy on the Market

Two adages capture the dilemma investors face when they consider buying a beaten-down stock:

These well-known sayings seem to be contradictory. However, they're not when taken in the correct

UnitedHealth's 6.4% Drop Brings Microsoft This Much Closer to Becoming the Most Important Stock in the Dow Jones Industrial Average: https://g.foolcdn.com/editorial/images/771795/gettyimages-1340542435-1201x511-15253f2.jpg
UnitedHealth's 6.4% Drop Brings Microsoft This Much Closer to Becoming the Most Important Stock in the Dow Jones Industrial Average

Microsoft (NASDAQ: MSFT) is currently the only company worth over $3 trillion. That makes it the most heavily weighted stock in both the S&P 500 and the Nasdaq Composite, but not the Dow Jones